Correlation Between Palisade Bio and Avenue Therapeutics
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Avenue Therapeutics, you can compare the effects of market volatilities on Palisade Bio and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Avenue Therapeutics.
Diversification Opportunities for Palisade Bio and Avenue Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Palisade and Avenue is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Palisade Bio i.e., Palisade Bio and Avenue Therapeutics go up and down completely randomly.
Pair Corralation between Palisade Bio and Avenue Therapeutics
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Avenue Therapeutics. In addition to that, Palisade Bio is 2.43 times more volatile than Avenue Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest 239.00 in Avenue Therapeutics on September 22, 2024 and sell it today you would lose (62.00) from holding Avenue Therapeutics or give up 25.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Palisade Bio vs. Avenue Therapeutics
Performance |
Timeline |
Palisade Bio |
Avenue Therapeutics |
Palisade Bio and Avenue Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Palisade Bio and Avenue Therapeutics
The main advantage of trading using opposite Palisade Bio and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Virax Biolabs Group | Avenue Therapeutics vs. Palisade Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |